Literature DB >> 6281733

Infectivity and structure of molecular clones obtained from two genetically transmitted Moloney leukemia proviral genomes.

K Harbers, A Schnieke, H Stuhlmann, R Jaenisch.   

Abstract

The Mov-2 and Mov-10 substrains of mice, each carrying Moloney leukemia virus (= M-MuLV) in their germ line at the Mov-2 and Mov-10 locus, respectively, do occasionally at a later age (Mov-2) or not at all (Mov-10) activate infectious virus. The M-MuLV proviruses with flanking mouse sequences corresponding to the Mov-2 and Mov-10 locus, respectively, were molecularly cloned. Restriction enzyme analysis revealed no major deletions or insertions in the proviral genomes of the Mov-2 and Mov-10 locus. Both cloned DNAs induced XC plaques in a transfection assay. The specific infectivity, however, was very low and 3T3 cells transfected with the Mov-2 or Mov-10 clone did not produce infectious virus. Removing part of the 5' cellular sequences from the Mov-10 clone did not increase the infectivity. The results suggest that the M-MuLV integrated at the Mov-2 and Mov-10 locus carry a mutation which prevents synthesis of infectious virus but permits XC plaque induction by partial genome expression or synthesis of non-infectious particles.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281733      PMCID: PMC320631          DOI: 10.1093/nar/10.8.2521

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Packaging recombinant DNA molecules into bacteriophage particles in vitro.

Authors:  B Hohn; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus.

Authors:  E Gilboa; S Goff; A Shields; F Yoshimura; S Mitra; D Baltimore
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Germ line integration of moloney leukemia virus: effect of homozygosity at the m-mulV locus.

Authors:  R Jaenisch
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

8.  Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus.

Authors:  R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

9.  Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal.

Authors:  R Jaenisch; H Fan; B Croker
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  12 in total

1.  Structure and expression of a gene encoding a putative GTP-binding protein identified by provirus integration in a transgenic mouse strain.

Authors:  K Mooslehner; U Müller; U Karls; L Hamann; K Harbers
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

2.  Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues.

Authors:  R Jaenisch; A Schnieke; K Harbers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

3.  Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication.

Authors:  Xiaojun Wang; Yanxing Han; Ying Dang; William Fu; Tao Zhou; Roger G Ptak; Yong-Hui Zheng
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

4.  Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites.

Authors:  H Rohdewohld; H Weiher; W Reik; R Jaenisch; M Breindl
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

5.  Human-mouse interspecies collagen I heterotrimer is functional during embryonic development of Mov13 mutant mouse embryos.

Authors:  H Wu; J F Bateman; A Schnieke; A Sharpe; D Barker; T Mascara; D Eyre; R Bruns; P Krimpenfort; A Berns
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions.

Authors:  K Mooslehner; U Karls; K Harbers
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Chromosomal position and specific demethylation in enhancer sequences of germ line-transmitted retroviral genomes during mouse development.

Authors:  D Jähner; R Jaenisch
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

8.  Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector.

Authors:  H Stuhlmann; R Cone; R C Mulligan; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Endogenous Moloney leukemia virus in nonviremic Mov substrains of mice carries defects in the proviral genome.

Authors:  A Schnieke; H Stuhlmann; K Harbers; I Chumakov; R Jaenisch
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

10.  Interaction of several related GC-box- and GT-box-binding proteins with the intronic enhancer is required for differential expression of the gb110 gene in embryonal carcinoma cells.

Authors:  L Hamann; K U Bayer; K Jensen; K Harbers
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.